COMPOSITIONS AND METHODS FOR MODULATING HBV AND TTR EXPRESSION

To provide conjugated antisense compounds comprising an antisense oligonucleotide complementary to a nucleic acid transcript.SOLUTION: The present invention provides a compound comprising a modified oligonucleotide and a conjugate group, where the modified oligonucleotide consists of 8 to 80 linked...

Full description

Saved in:
Bibliographic Details
Main Authors SETH PUNIT P, PRAKASH THAZHA P, SWAYZE ERIC E
Format Patent
LanguageEnglish
Japanese
Published 29.07.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To provide conjugated antisense compounds comprising an antisense oligonucleotide complementary to a nucleic acid transcript.SOLUTION: The present invention provides a compound comprising a modified oligonucleotide and a conjugate group, where the modified oligonucleotide consists of 8 to 80 linked nucleosides and has a nucleobase sequence at least 85%, 90%, 95%, or 100% complementary to a sequence encoding transthyretin.SELECTED DRAWING: None 【課題】核酸転写物に相補的なアンチセンスオリゴヌクレオチドを含む共役アンチセンス化合物を提供する。【解決手段】修飾オリゴヌクレオチドおよびコンジュゲート基を含む化合物であって、修飾オリゴヌクレオチドが、8〜80個の連結したヌクレオシドからなり、かつトランスサイレチンをコードする配列に少なくとも85%、90%、95%、または100%相補的な核酸塩基配列を有する、化合物である。【選択図】なし
Bibliography:Application Number: JP20210065088